» Articles » PMID: 35858831

Anesthesia Promotes Acute Expression of Genes Related to Alzheimer's Disease and Latent Tau Aggregation in Transgenic Mouse Models of Tauopathy

Overview
Journal Mol Med
Publisher Biomed Central
Date 2022 Jul 20
PMID 35858831
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Exposure to anesthesia in the elderly might increase the risk of dementia. Although the mechanism underlying the association is uncertain, anesthesia has been shown to induce acute tau hyperphosphorylation in preclinical models. We sought to investigate the impact of anesthesia on gene expression and on acute and long-term changes in tau biochemistry in transgenic models of tauopathy in order to better understand how anesthesia influences the pathophysiology of dementia.

Methods: We exposed mice with over-expressed human mutant tau (P301L and hyperdopaminergic COMTKO/P301L) to two hours of isoflurane and compared anesthetized mice to controls at several time points. We evaluated tau hyperphosphorylation with quantitative high-sensitivity enzyme-linked immunosorbent assay and performed differential expression and functional transcriptome analyses following bulk mRNA-sequencing.

Results: Anesthesia induced acute hyperphosphorylation of tau at epitopes related to Alzheimer's disease (AD) in both P301L-based models. Anesthesia was associated with differential expression of genes in the neurodegenerative pathways (e.g., AD-risk genes ApoE and Trem2) and thermogenesis pathway, which is related to both mammalian hibernation and tau phosphorylation. One and three months after anesthesia, hyperphosphorylated tau aggregates were increased in the anesthetized mice.

Conclusions: Anesthesia may influence the expression of AD-risk genes and induce biochemical changes in tau that promote aggregation even after single exposure. Further preclinical and human studies are necessary to establish the relevance of our transcriptomic and biochemical findings in these preclinical models to the pathogenesis of dementia following anesthesia.

Trial Registration: Not applicable.

Citing Articles

p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.

Taylor L, Simzer E, Pimblett C, Lacey-Solymar O, McGeachan R, Meftah S Acta Neuropathol. 2024; 147(1):7.

PMID: 38175261 PMC: 10766794. DOI: 10.1007/s00401-023-02667-w.


The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [C] Raclopride Binding in Tau Mouse Models of Alzheimer's Disease.

Jimenez H, Carrion J, Adrien L, Wolin A, Eun J, Cinamon E Biomedicines. 2023; 11(8).

PMID: 37626588 PMC: 10452133. DOI: 10.3390/biomedicines11082091.

References
1.
Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M . New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2018; 47(D1):D590-D595. PMC: 6324070. DOI: 10.1093/nar/gky962. View

2.
Cahoy J, Emery B, Kaushal A, Foo L, Zamanian J, Christopherson K . A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008; 28(1):264-78. PMC: 6671143. DOI: 10.1523/JNEUROSCI.4178-07.2008. View

3.
Yang T, Velagapudi R, Terrando N . Neuroinflammation after surgery: from mechanisms to therapeutic targets. Nat Immunol. 2020; 21(11):1319-1326. PMC: 7704062. DOI: 10.1038/s41590-020-00812-1. View

4.
Evered L, Silbert B, Scott D, Zetterberg H, Blennow K . Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery: Results From the CAPACITY and ARCADIAN Studies. JAMA Neurol. 2018; 75(5):542-547. PMC: 5885271. DOI: 10.1001/jamaneurol.2017.4913. View

5.
Whittington R, Virag L, Marcouiller F, Papon M, Khoury N, Julien C . Propofol directly increases tau phosphorylation. PLoS One. 2011; 6(1):e16648. PMC: 3031597. DOI: 10.1371/journal.pone.0016648. View